compound 10

NFAT:AP-1 inhibitor-10 is a novel inhibitor of the NFAT:AP-1:DNA interaction on the ARRE-2 element, binding to DNA in a sequence-selective manner and inhibiting the transcription of the Il2 gene and several other cyclosporin A-sensitive cytokine genes important for the effector immune response.

MINA53 inhibitor (Compound 10) is an inhibitor of MINA53.

Compound 102-09-0, with CAS No. 102-09-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 102-09-0 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1245816-10-7, with CAS No. 1245816-10-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1245816-10-7 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 105655-01-4, with CAS No. 105655-01-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 105655-01-4 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1049755-55-6, with CAS No. 1049755-55-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1049755-55-6 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1060815-90-8, with CAS No. 1060815-90-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1060815-90-8 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 10166-54-8, with CAS No. 10166-54-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 10166-54-8 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 103646-82-8, with CAS No. 103646-82-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 103646-82-8 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1011-50-3, with CAS No. 1011-50-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1011-50-3 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 106058-85-9, with CAS No. 106058-85-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 106058-85-9 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 100124-06-9, with CAS No. 100124-06-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 100124-06-9 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 100960-07-4, with CAS No. 100960-07-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 100960-07-4 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1085192-91-1, with CAS No. 1085192-91-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1085192-91-1 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1013-76-9, with CAS No. 1013-76-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 1013-76-9 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 1080-0560 is a useful organic compound for research related to life sciences and the catalog number is T100886.

Compound 1080-0568 is a useful organic compound for research related to life sciences and the catalog number is T101208.

Compound 1080-0561 is a useful organic compound for research related to life sciences and the catalog number is T93832.

Terbogrel is an oral thromboxane A2 receptor antagonist (IC50 is about 10 nM) and thromboxane A2 synthase inhibitor (IC50 is about 10 nM). Terbogrel is an antiplatelet compound that inhibits platelet aggregation and is a potential compound for the prevention of blood clots.

NO-prednisolone (NCX-1015) is a compound that effectively stimulates the production of IL-10 in vivo. It is a Prednisolone derivative that releases nitric oxide (NO).

SU11652 is an effective and competitive receptor tyrosine kinase (RTK) inhibitor, including VEGFR, FGFR, PDGFR, and Kit. SU11652 disrupts the function of all forms of mutant Kit and may be used in the study of cancers involving Kit mutations.

10-FTHF is a donor of formyl groups in anabolism used as a substrate in formyltransferase reactions, which is important in purine biosynthesis.This compound is unstable in powder form and other related salt forms are recommended.

IRAK4-IN-10 (compound 75) is a potent IRAK4 inhibitor (IC50 = 1.5 nM) that can block the MyD88-dependent signaling pathway and has research potential in inflammatory diseases, autoimmune diseases, and cancer.

Milataxel is an orally bioavailable taxane with potential antineoplastic activity. Upon oral administration, milataxel and its major active metabolite M-10 bind to and stabilize tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2 M phase, and the inhibition of tumor cell proliferation. Unlike other taxane compounds, milataxel appears to be a poor substrate for the multidrug resistance (MDR) membrane-associated P-glycoprotein (P-gp) efflux pump and may be useful for treating multidrug-resistant tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).This compound is unstable in powder form and other related salt forms are recommended.